Eculizumab as first line treatment for patients with severe presentation of Complement Factor H antibodies mediated Hemolytic Uremic Syndrome
Preprint in Research Square (June 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Preprint in Research Square (June 2024)
Article in Cureus (May 2024)
Article in Kidney International Reports (May 2024)